Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

BACKGROUND: Bushen Jianpi formula (BSJPF, also known as Lingmao formula) is a traditional Chinese medicine for chronic hepatitis B (CHB). The previous study has suggested that the treatment combination of BSJPF and entecavir (ETV) can achieve a significant loss of hepatitis B e antigen (HBeAg) and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing-Hao, Zhang, Xin, Zhou, Zhen-Hua, Zhu, Xiao-Jun, Zheng, Chao, Li, Man, Jin, Shu-Gen, Mao, De-Wen, Xue, Jing-Dong, Shi, Wei-Bing, Chi, Xiao-Ling, Wang, Xian-Bo, Li, Xiao-Dong, Li, Yong, Wang, Hui, Li, Qin, Zhou, Da-Qiao, Wang, Cheng-Bao, Shi, Chang-He, Li, Cheng-Zhong, Wu, Jian-Hua, Kong, Xiao-Ni, Sun, Xue-Hua, Gao, Yue-Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975667/
https://www.ncbi.nlm.nih.gov/pubmed/35368769
http://dx.doi.org/10.1155/2022/6097221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975667/
https://www.ncbi.nlm.nih.gov/pubmed/35368769
http://dx.doi.org/10.1155/2022/6097221

Ejemplares similares